Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov-Dec;75(6):391-397.
doi: 10.1016/j.ihj.2023.10.007. Epub 2023 Oct 26.

Anti-inflammatory therapy in atherosclerotic cardiovascular disease: Current reappraisal

Affiliations
Editorial

Anti-inflammatory therapy in atherosclerotic cardiovascular disease: Current reappraisal

Subrat Muduli et al. Indian Heart J. 2023 Nov-Dec.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Residual Inflammatory CV Risk and Results of the studies targeting the pathway. AFCAPS/TexCAPS; Air Force/Texas Coronary atherosclerosis prevention Study, PROVE-IT; The PRavastatin Or atorVastatin Evaluation and Infection Therapy, IMPROVE-IT; Improved Reduction of Outcomes: Vytorin Efficacy International Trial, JUPITER; Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin, CANTOS; Canakinumab Anti-Inflammatory Thrombosis Outcome Study, ASSAIL-MI Assessing the Effect of Anti‐IL‐6 Treatment in Myocardial Infarction, LoDoCo; Low Dose Colchicine, COLCOT Colchicine Cardiovascular Outcomes Trial. MACE-Major Adverse Cardiovascular Events, CAD-Coronary Artery Disease, CV- Cardiovascular.
Fig. 2
Fig. 2
NLRP3 inflammasome to hsCRP inflammatory pathway and drug targets at various levels. NLRP- Nucleotide-binding oligomerization domain Leucine rich Repeat and Pyrin domain containing, ASC- Apoptosis-associated speck-like protein containing a caspase activation and recruitment domain, IL-1-Interleukin 1, CRP-C reactive Protein, PAI- Plasminogen Activator Inhibitor.

References

    1. Ference B.A., Ginsberg H.N., Graham I., et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459–2472. - PMC - PubMed
    1. Deloukas P., Kanoni S., Willenborg C., et al. CARDIoGRAMplusC4D Consortium. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25–33. - PMC - PubMed
    1. Esdaile J.M., Abrahamowicz M., Grodzicky T., et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001 Oct;44(10):2331–2337. - PubMed
    1. Prodanovich S., Kirsner R.S., Kravetz J.D., Ma F., Martinez L., Federman D.G. Association of Psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol. 2009;145(6):700–703. - PubMed
    1. Laurila A., Bloigu A., Näyhä S., Hassi J., Leinonen M., Saikku P. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis. 1999 Jan;142(1):207–210. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources